Back to search
FDAFDA · Food and drugs·Recall number D-1128-2018

0.9% Sodium Chloride Injection USP 100 mL bags, Rx only, Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 0338-0049-18

Published September 5, 2018 · Recall initiated: August 21, 2018

Summary

FDA records drug Class II recall D-1128-2018, published September 5, 2018 and initiated August 21, 2018. Recalling firm: Baxter Healthcare Corporation; Status: Terminated; Reported quantity: 33600 bags; Lot: Lot #: P380287, Exp. date 12/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email if SODIUM CHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SODIUM CHLORIDE
Manufacturer
Baxter Healthcare Corporation
Distributor
TX and MS only
Lot
Lot #: P380287, Exp. date 12/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.9% Sodium Chloride Injection USP 100 mL bags, Rx only, Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 0338-0049-18 recalled?

Yes. FDA published recall D-1128-2018 on September 5, 2018. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SODIUM CHLORIDE.